Risultati ricerca autore :: APM

1

Subcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: a time and motion study in the United Kingdom di Simon Rule, Graham P. Collins, Kunal Samanta

Pubblicazione 2014

Testo
Artigo

Aggiungi alla lista

Salvato in:
2

What do we know about duodenal‐type follicular lymphoma? From pathological definition to treatment options di Guilherme Duffles, Graham P. Collins, Vanderson Rocha

Pubblicazione 2019

Testo Testo
Revisão

Aggiungi alla lista

Salvato in:
3

Anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease di Toby A. Eyre, Dalia Khan, Georgina Hall, Graham P. Collins

Pubblicazione 2014

Testo Testo
Revisão

Aggiungi alla lista

Salvato in:
4

Nodular lymphocyte-predominant Hodgkin lymphoma: advances in disease biology, risk stratification, and treatment di Ross Salvaris, Benjamin Allanson, Graham P. Collins, Chan Y. Cheah

Pubblicazione 2024

Testo
Revisão

Aggiungi alla lista

Salvato in:
5

Time now to<scp>TORC</scp>the<scp>TORC</scp>? New developments in m<scp>TOR</scp>pathway inhibition in lymphoid malignancies di Toby A. Eyre, Graham P. Collins, Anthony H. Goldstone, Kate Cwynarski

Pubblicazione 2014

Testo Testo
Revisão

Aggiungi alla lista

Salvato in:
6

Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in... di Toby A. Eyre, Faouzi Djebbari, Amy A. Kirkwood, Graham P. Collins

Pubblicazione 2019

Testo Testo
Revisão

Aggiungi alla lista

Salvato in:
7

Care of haematology patients in a COVID‐19 epidemic di John Willan, Andrew J. King, Sandy Hayes, Graham P. Collins, Andrew Peniket

Pubblicazione 2020

Testo
Artigo

Aggiungi alla lista

Salvato in:
8

Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre di Richard Haynes, Simon Read, Graham P. Collins, Sarah C. Darby, Christopher G. Winearls

Pubblicazione 2009

Testo Testo
Artigo

Aggiungi alla lista

Salvato in:
9

Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with<i>de novo</i>di... di Toby A. Eyre, Richard Anthony Salisbury, David W. Eyre, Caroline Watson, Graham P. Collins, Chris S.R Hatton

Pubblicazione 2015

Testo Testo
Carta

Aggiungi alla lista

Salvato in:
10

$Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy$

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy di Toby A. Eyre, Harriet S. Walter, Sunil Iyengar, George Follows, Matt Cross, Christopher P. Fox, Andrew Hodson, Josh T. Coats, Santosh Narat, Nicholas Morley, Martin J.S. Dyer, Graham P. Collins

Pubblicazione 2018

Testo Testo
Carta

Aggiungi alla lista

Salvato in:
11

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma di Sean H. Lim, Nicola Campbell, Marina Johnson, Débora Joseph‐Pietras, Graham P. Collins, Ann O’Callaghan, Christopher P. Fox, Matthew J. Ahearne, Peter Johnson, David Goldblatt, Andrew Davies

Pubblicazione 2021

Testo
Artigo

Aggiungi alla lista

Salvato in:
12

Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline di George Follows, Sally F. Barrington, Kaljit Bhuller, Dominic Culligan, David J. Cutter, Eve Gallop‐Evans, Shireen Kassam, Wendy Osborne, Shalal Sadullah, William Townsend, Benjamin J. Uttenthal, Graham P. Collins

Pubblicazione 2022

Testo
Revisão

Aggiungi alla lista

Salvato in:
13

Seronegative antibody‐mediated neurology after immune checkpoint inhibitors di R. Wilson, David A. Menassa, Alexander J. Davies, Sophia Michael, Joanna Hester, Wilhelm Küker, Graham P. Collins, Judith Cossins, David Beeson, Neil Steven, Paul Maddison, Simon Rinaldi, Saiju Jacob, Sarosh R. Irani

Pubblicazione 2018

Testo Testo
Artigo

Aggiungi alla lista

Salvato in:
14

$Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study$

Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study di Michael Wang, Radhakrishnan Ramchandren, Robert Chen, Lionel Karlin, Geoffrey Chong, Wojciech Jurczak, Ka Lung Wu, Mark Bishton, Graham P. Collins, Paul Eliadis, Fréderic Peyrade, Yihua Lee, Karl Eckert, Jutta K. Neuenburg, Constantine S. Tam

Pubblicazione 2021

Testo Testo
Artigo

Aggiungi alla lista

Salvato in:
15

$Magrolimab Plus Rituximab in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Phase 1/2 Trial 3-Year Follow-up$

Magrolimab Plus Rituximab in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: Phase 1/2 Trial 3-Year Follow-up di Amitkumar Mehta, Leslie Popplewell, Graham P. Collins, Sonali M. Smith, Ian W. Flinn, Nancy L. Bartlett, Nilanjan Ghosh, Gal Hacohen-Kleiman, Yanan Huo, Linda Su-Feher, Camille Renard, Ranjana H. Advani, Mark Roschewski

Pubblicazione 2024

Testo
Artigo

Aggiungi alla lista

Salvato in:
16

Identification of a Novel Mutation in MAGT1 and Progressive Multifocal Leucoencephalopathy in a 58-Year-Old Man with XMEN Disease di Fatima Dhalla, Sarah Murray, Ross Sadler, Benjamin Chaigne-Delalande, Tomohiko Sadaoka, Elizabeth J. Soilleux, Gülbû Uzel, J. Philip Miller, Graham P. Collins, Christian S. R. Hatton, Malini Bhole, Berne Ferry, Helen Chapel, Jeffrey I. Cohen, Smita Y. Patel

Pubblicazione 2014

Testo
Revisão

Aggiungi alla lista

Salvato in:
17

$Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies$

Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies di Emma Searle, Francesco Forconi, Kim Linton, Alexey V. Danilov, Pam McKay, David John Lewis, Dima El‐Sharkawi, Mary Gleeson, John C. Riches, Sarah G. Injac, Ted Shih, Srinand Nandakumar, May Tan, Ganesh Cherala, Erin Meredith, Graham P. Collins

Pubblicazione 2023

Testo
Artigo

Aggiungi alla lista

Salvato in:
18

$Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma$

Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma di Ariela Noy, Sven de Vos, Catherine Thiéblemont, Peter Martin, Christopher R. Flowers, Franck Morschhauser, Graham P. Collins, Shuo Ma, Morton Coleman, Shachar Peles, Stephen D. Smith, Jacqueline C. Barrientos, Alina Smith, Brian Munneke, Isaiah W. Dimery, Darrin M. Beaupre, Robert Chen

Pubblicazione 2017

Testo Testo
Artigo

Aggiungi alla lista

Salvato in:
19

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety di Wolfgang Hiddemann, Anna Maria Barbui, Miguel Canales, Paul Cannell, Graham P. Collins, Jan Dürig, Roswitha Forstpointner, Michael Herold, Mark Hertzberg, Magdalena Klánová, John Radford, John F. Seymour, Kensei Tobinai, Judith Trotman, Alis Burciu, Günter Fingerle‐Rowson, Marcel Wolbers, Tina Nielsen, Robert Marcus

Pubblicazione 2018

Testo
Artigo

Aggiungi alla lista

Salvato in:
20

Stand‐alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R‐CHOP and is associate... di Toby A. Eyre, Amy A. Kirkwood, Julia Wolf, Catherine Hildyard, Carolyn Mercer, Hannah Plaschkes, John Griffith, Paul Fields, Arief Gunawan, Rebecca Oliver, Stephen Booth, Nicolás Martínez‐Calle, Andrew McMillan, Mark Bishton, Christopher P. Fox, Graham P. Collins, Chris S.R Hatton

Pubblicazione 2019

Testo Testo
Artigo

Aggiungi alla lista

Salvato in: